Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 StudyClin. Cancer Res 2021 Mar 16;[EPub Ahead of Print], SM Tolaney, K Kalinsky, V Kaklamani, DR D'Adamo, G Aktan, ML Tsai, RM O'Regan, PA Kaufman, ST Wilks, E Andreopoulou, DA Patt, Y Yuan, G Wang, C Savulsky, D Xing, E Kleynerman, V Karantza, S Diab
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.